Artal Group’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-256,400
| Closed | -$315K | – | 117 |
|
|
2019
Q1 | $315K | Hold |
256,400
| – | – | 0.01% | 88 |
|
|
2018
Q4 | $215K | Hold |
256,400
| – | – | 0.01% | 79 |
|
|
2018
Q3 | $759K | Hold |
256,400
| – | – | 0.02% | 82 |
|
|
2018
Q2 | $944K | Hold |
256,400
| – | – | 0.02% | 75 |
|
|
2018
Q1 | $897K | Hold |
256,400
| – | – | 0.01% | 79 |
|
|
2017
Q4 | $800K | Hold |
256,400
| – | – | 0.01% | 80 |
|
|
2017
Q3 | $1.8M | Hold |
256,400
| – | – | 0.03% | 66 |
|
|
2017
Q2 | $2.37M | Hold |
256,400
| – | – | 0.04% | 64 |
|
|
2017
Q1 | $2.75M | Hold |
256,400
| – | – | 0.06% | 55 |
|
|
2016
Q4 | $2.16M | Buy |
+256,400
| New | +$2.16M | 0.05% | 49 |
|